NL-OMON24991尚未招募不适用
PHARMACOKINETICS OF APREPITANT, DEXAMETHASONE AND THEIR INTERACTION IN CHILDREN WITH CHEMOTHERAPY INDUCED NAUSEA AND VOMITING: A PILOT STUDY
Princess Maxima Center for pediatric oncology0 个研究点目标入组 99 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 99
研究概览
简要总结
Kang HJ, Loftus S, Taylor A, DiCristina C, Green S, Zwaan CM. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial. The Lancet. Oncology. Apr 2015;16(4):385-394
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •1. Planned to receive chemotherapy intravenously as regular treatment (standard of care);
排除标准
- •see eligibility criteria above
研究者
相似试验
已完成
3 期
Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic ChemotherapyGastrointestinal NeoplasmsChemotherapy-induced Nausea and VomitingNCT03674294Sun Yat-sen University248
Unknown
3 期
Aprepitant for the Prevention of Chemotherapy-induced Nausea and VomitingChemotherapy-induced Nausea and VomitingNCT02933099Wuhan Union Hospital, China300
已完成
不适用
PHARMACOKINETICS OF APREPITANT, DEXAMETHASONE AND THEIR INTERACTION IN CHILDREN WITH CHEMOTHERAPY INDUCED NAUSEA AND VOMITING: A PILOT STUDYpharmacokinetics of antiemetics for chemotherapy induced vomiting and nausea1001794710027655NL-OMON48783Prinses Máxima Centrum voor Kinderoncologie99
招募中
不适用
PHARMACOKINETICS OF APREPITANT, DEXAMETHASONE AND THEIR INTERACTION IN PATIENTS WITH CHEMOTHERAPY INDUCED NAUSEA AND VOMITINGChemotherapy induced vomiting and nausea1001801210027655NL-OMON52052Antoni van Leeuwenhoek Ziekenhuis20
已完成
4 期
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having CraniotomyPostoperative Nausea and VomitingNCT00734929Duke University115